Alpine Immune Sciences, Inc. Profile Avatar - Palmy Investing

Alpine Immune Sciences, Inc.

Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline i…

Biotechnology
US, Seattle [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Alpine Immune Sciences, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of ALPN's Analysis
CIK: 1626199 CUSIP: 02083G100 ISIN: US02083G1004 LEI: - UEI: -
Secondary Listings
ALPN has no secondary listings inside our databases.